Xie Yuexia, Tu Wenzhi, Zhang Jianghong, He Mingyuan, Ye Shuang, Dong Chen, Shao Chunlin
Institute of Radiation Medicine, Fudan University, Shanghai, China; Central Laboratory, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Institute of Radiation Medicine, Fudan University, Shanghai, China.
Mutat Res. 2015 Feb;772:23-9. doi: 10.1016/j.mrfmmm.2014.12.010. Epub 2015 Jan 3.
Radiation-induced bystander effect (RIBE) has important implications for secondary cancer risk assessment during cancer radiotherapy, but the bystander signaling processes, especially under hypoxic condition, are still largely unclear. The present study found that micronuclei (MN) formation could be induced in the non-irradiated HL-7702 hepatocyte cells after being treated with the conditioned medium from irradiated hepatoma HepG2 and SK-Hep-1 cells under either normoxia or hypoxia. This bystander response was dramatically diminished or enhanced when the SirT1 gene of irradiated hepatoma cells was overexpressed or knocked down, respectively, especially under hypoxia. Meanwhile, SirT1 knockdown promoted transcriptional activity for c-Myc and facilitated ROS accumulation. But both of the increased bystander responses and ROS generation due to SirT1-knockdown were almost completely suppressed by c-Myc interference. Moreover, ROS scavenger effectively abolished the RIBE triggered by irradiated hepatoma cells even with SirT1 depletion. These findings provide new insights that SirT1 has a profound role in regulating RIBE where a c-Myc-dependent release of ROS may be involved.
辐射诱导旁观者效应(RIBE)对癌症放疗期间的继发性癌症风险评估具有重要意义,但旁观者信号传导过程,尤其是在缺氧条件下,仍 largely不清楚。本研究发现,在常氧或缺氧条件下,用来自照射过的肝癌HepG2和SK-Hep-1细胞的条件培养基处理后,未照射的HL-7702肝细胞中可诱导微核(MN)形成。当照射过的肝癌细胞的SirT1基因分别过表达或敲低时,这种旁观者反应会显著减弱或增强,尤其是在缺氧条件下。同时,SirT1敲低促进了c-Myc的转录活性并促进了ROS积累。但由于SirT1敲低导致的旁观者反应增加和ROS生成几乎都被c-Myc干扰完全抑制。此外,即使在SirT1缺失的情况下,ROS清除剂也有效地消除了照射过的肝癌细胞触发的RIBE。这些发现提供了新的见解,即SirT1在调节RIBE中具有重要作用,其中可能涉及c-Myc依赖的ROS释放。
Int J Radiat Biol. 2013-7-24
Int J Radiat Biol. 2015-5
Toxicol Appl Pharmacol. 2012-1-5
Antioxidants (Basel). 2022-11-1
Front Cell Dev Biol. 2021-3-25
Oxid Med Cell Longev. 2019-2-6
PLoS One. 2018-4-5